Does CANAKINUMAB Cause C-reactive protein abnormal? 127 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 127 reports of C-reactive protein abnormal have been filed in association with CANAKINUMAB (Ilaris). This represents 1.2% of all adverse event reports for CANAKINUMAB.
127
Reports of C-reactive protein abnormal with CANAKINUMAB
1.2%
of all CANAKINUMAB reports
57
Deaths
101
Hospitalizations
How Dangerous Is C-reactive protein abnormal From CANAKINUMAB?
Of the 127 reports, 57 (44.9%) resulted in death, 101 (79.5%) required hospitalization, and 114 (89.8%) were considered life-threatening.
Is C-reactive protein abnormal Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CANAKINUMAB. However, 127 reports have been filed with the FAERS database.
What Other Side Effects Does CANAKINUMAB Cause?
Pyrexia (1,327)
Inappropriate schedule of drug administration (1,238)
Drug ineffective (1,078)
Inappropriate schedule of product administration (944)
Pain (858)
Condition aggravated (771)
Malaise (684)
Off label use (557)
Arthralgia (555)
Rash (505)
What Other Drugs Cause C-reactive protein abnormal?
METHOTREXATE (3,734)
ADALIMUMAB (3,629)
ETANERCEPT (3,592)
ABATACEPT (3,402)
LEFLUNOMIDE (3,279)
TOCILIZUMAB (3,259)
HYDROXYCHLOROQUINE (3,245)
SULFASALAZINE (2,823)
INFLIXIMAB (2,676)
RITUXIMAB (2,608)
Which CANAKINUMAB Alternatives Have Lower C-reactive protein abnormal Risk?
CANAKINUMAB vs CANDESARTAN
CANAKINUMAB vs CANDESARTAN CILEXETIL
CANAKINUMAB vs CANDESARTAN CILEXETIL\HYDROCHLOROTHIAZIDE
CANAKINUMAB vs CANGRELOR
CANAKINUMAB vs CANIS LUPUS FAMILIARIS SKIN